fda status bpc-157 2024 aka Wolverine. This peptide is not FDA-approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn’t have human data yet, so FDA removes BPC-157, KPV, Semax
Description
Del Rey et al., 2024)

58 For NSAIDs-adverse effects (i.e., gastrointestinal, liver and brain injuries), BPC 157 counteraction includes both COX-1 and COX-2 blockers

Journal of Molecular Endocrinology, 52 (1)
The answer, as with all things in research, is: it depends on the model and the objective